Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2025 Jun 10;20(6):e0321873.
doi: 10.1371/journal.pone.0321873. eCollection 2025.

Extended-spectrum β-lactamase-producing Enterobacterales among people living with human immunodeficiency virus across the globe: A systematic review and meta-analysis

Affiliations
Meta-Analysis

Extended-spectrum β-lactamase-producing Enterobacterales among people living with human immunodeficiency virus across the globe: A systematic review and meta-analysis

Mitkie Tigabie et al. PLoS One. .

Abstract

Background: People living with HIV are vulnerable to antibiotic-resistant bacterial infections because of frequent healthcare visits, the consumption of many antimicrobials, and the weakened immune system to fight infections. Our objective was to provide comprehensive data about ESBL-producing Enterobacterales among HIV-positive individuals across the globe.

Methods: This meta-analysis was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. To select eligible articles published between January 1, 2010, and May 12, 2024, a literature search was performed on available electronic databases such as PubMed, Hinari, Google Scholar, and Scopus. The quality of the included studies was assessed via the Joanna Briggs Institute critical appraisal tool. The data were extracted from the eligible studies via Microsoft Excel 2019 and analyzed via STATA version 17. A random effects model was constructed via the DerSimonian and Laird method. The heterogeneity was checked through the Cochrane Q statistic, and the magnitude was quantitatively measured via I2 statistics. To determine the possible sources of heterogeneity, a subgroup analysis was performed. Additionally, a sensitivity analysis was conducted, and publication bias was checked via funnel plots and Egger's regression tests. A p value of less than 0.05 was considered evidence of heterogeneity and small study effects according to the Cochrane Q statistic and Egger's test, respectively. The protocol was registered previously (PROSPERO ID: CRD42024557981).

Results: A total of 5305 HIV-positive individuals from 20 studies were included in our meta-analysis. The overall pooled prevalence of ESBL-producing Enterobacterales among HIV-positive individuals was 20.30% (931/5305; 95% CI: 15.13-25.47%, P < 0.001), with a high level of heterogeneity (I2 = 97.82%, P < 0.001). The predominant ESBL producers were K. pneumoniae, with a pooled prevalence of 40.84% (76/217; 95% CI: 26.87-54.81%), followed closely by E. coli at 40.14% (348/985; 95% CI: 27.83-52.45%). In the subgroup analysis, the highest magnitude of ESBL-producing pathogens was observed in Asia (195/715; 28.55%), followed by Africa (666/3981; 19.12%). Additionally, the highest pooled prevalence of ESBL-producing pathogens among HIV-positive individuals was reported to be colonization 23.78% (613/2455; 95% CI: 15.36-32.19, I² = 96.78%, p < 0.001), followed by infection 15.77% (318/2850; 95% CI: 10.06-21.49, I² = 97.45%, p < 0.001). Among the different types of ESBL enzyme-encoding genes, blaCTX-M was the most common (73 out of 150 isolates, 48.7%), followed by blaTEM (49 out of 150, 32.7%).

Conclusion and recommendations: This study demonstrated that HIV-positive individuals are commonly colonized and infected with ESBL-producing Enterobacterales. The highest prevalence of these pathogens was reported in Asia and Africa. To reduce mortality from severe bacterial infections in HIV patients, resources should be distributed equitably across all regions. Particular attention should be given to high-prevalence areas, where early detection of colonization and infection with antibiotic-resistant pathogens is critical. Enhanced surveillance of ESBL-producing organisms among HIV-positive individuals is also strongly recommended.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. A flow diagram of study selection for systematic review and meta-analysis of ESBL-producing Enterobacterales among HIV-positive individuals.
Fig 2
Fig 2. Forest plot showing overall pooled prevalence of ESBL-producing Enterobacterales among HIV-positive individuals.
Fig 3
Fig 3. Forest plot for the pooled prevalence of ESBL-producing Enterobacterales among infection case.
Fig 4
Fig 4. Forest plot for the pooled prevalence of ESBL-producing Enterobacterales among colonization case.
Fig 5
Fig 5. Forest plot showing the pooled prevalence of ESBL-producing K. pneumoniae among HIV-positive individuals.
Fig 6
Fig 6. Forest plot showing the pooled prevalence of ESBL-producing E. coli among HIV-positive individuals.
Fig 7
Fig 7. Funnel plot showing publication bias for ESBL-producing Enterobacterales among HIV-positive individuals.
Fig 8
Fig 8. Subgroup analysis of ESBL-producing Enterobacterales among HIV-positive individuals by continent.
Fig 9
Fig 9. Subgroup analysis of ESBL-producing Enterobacterales by year of publication.
Fig 10
Fig 10. Forest plot showing subgroup analysis of ESBL-producing Enterobacterales via age categories.
Fig 11
Fig 11. Forest plot showing subgroup analysis of ESBL-producing Enterobacterales via investigation methods.

Similar articles

References

    1. World Health Organization. Ten threats to global health 2019. [Available from: https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-....
    1. Naghavi M, Vollset SE, Ikuta KS, Swetschinski LR, Gray AP, Wool EE, et al. Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050. Lancet. 2024;404(10459):1199–226. doi: 10.1016/S0140-6736(24)01867-1 - DOI - PMC - PubMed
    1. Walsh TR, Gales AC, Laxminarayan R, Dodd PC. Antimicrobial resistance: addressing a global threat to humanity. PLoS Med. 2023;20(7):e1004264. doi: 10.1371/journal.pmed.1004264 - DOI - PMC - PubMed
    1. Sartorius B GA, Weaver ND, Aguilar GR, Swetschinski LR, Ikuta KS et al. The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis. Lancet Glob Health. 2024;12(2):e201–16. doi: 10.1016/S2214-109X(23)00539-9 - DOI - PMC - PubMed
    1. Mestrovic T AG, Swetschinski LR, Ikuta KS, Gray AP, Weaver ND et al. The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis. Lancet Public Health. 2022;7(11):e897–913. doi: 10.1016/S2468-2667(22)00225-0 - DOI - PMC - PubMed

MeSH terms